Press release Biocartis Group NV: Results of the Annual Shareholders’ Meeting held on 13 May 2022
May 13, 2022 11:40 ET
|
Biocartis NV
PRESS RELEASE: 13 May 2022, 17:40 CEST Results of the Annual Shareholders’ Meeting held on 13 May 2022 Mechelen, Belgium, 13 May 2022 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an...
Braces on Demand Secures Investment to Scale 3D Tech Nationally, While Celebrating Second AAO Innovation Award
May 10, 2022 10:11 ET
|
Braces On Demand
HICKSVILLE, N.Y., May 10, 2022 (GLOBE NEWSWIRE) -- Orthodontists across the U.S. can now control their own manufacturing and supply chains with Braces On Demand, an online 3D printing platform for...
Access Vascular Inc. Named 2022 MedTech Breakthrough Award Winner
May 10, 2022 08:00 ET
|
Access Vascular
BILLERICA, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI) today announced it has been named “Best New Technology Solution – Drug Delivery” in the 2022 MedTech Breakthrough...
Access Vascular Receives FDA Clearance for HydroPICC® Biomaterial-Based Dual-Lumen Catheter
May 05, 2022 11:48 ET
|
Access Vascular
BILLERICA, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI) today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its HydroPICC®...
SmileDirectClub Wins “Best Telehealth Platform” Award From MedTech Breakthrough
May 05, 2022 08:00 ET
|
SmileDirectClub, LLC
NASHVILLE, Tenn., May 05, 2022 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (Nasdaq: SDC), the next generation oral care company with the first medtech platform for teeth straightening, has been...
Heart Centre Rigshospitalet Copenhagen Celebrates 5,000 Robotic Cardiac Ablation Procedures
May 04, 2022 09:07 ET
|
Stereotaxis, Inc.
ST. LOUIS, May 04, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, celebrates the achievements of...
Persbericht Biocartis Group NV: Nieuwe studie geleid door Memorial Sloan Kettering Cancer Center (NY, VS) toont dat Idylla™ GeneFusion Assay snellere screening van gerichte genfusies toelaat in vergelijking met routinemethoden
May 04, 2022 01:00 ET
|
Biocartis NV
PERSBERICHT: 4 mei 2022, 07:00 CEST Nieuwe studie geleid door Memorial Sloan Kettering Cancer Center (NY, VS) toont dat Idylla™ GeneFusion Assay snellere screening van gerichte genfusies toelaat in...
Press release Biocartis Group NV: New Study Led by Memorial Sloan Kettering Cancer Center (NY, US) Shows Idylla™ GeneFusion Assay Enables More Rapid Screening of Targetable Fusions Compared to Routine Methods
May 04, 2022 01:00 ET
|
Biocartis NV
PRESS RELEASE: 4 May 2022, 07:00 CEST New Study Led by Memorial Sloan Kettering Cancer Center (NY, US) Shows Idylla™ GeneFusion Assay Enables More Rapid Screening of Targetable Fusions Compared to...
Province supports MedTech Centre of Excellence at Medical Innovation Xchange (MIX)
May 03, 2022 14:12 ET
|
Medical Innovation Xchange
Kitchener, ON, Canada,, May 03, 2022 (GLOBE NEWSWIRE) -- Medical Innovation Xchange (MIX) is pleased to announce an innovative partnership with the Ontario Ministry of Labour, Training and Skills...
NovaSignal’s Morphology Capability Provides New Insight to Physicians
April 28, 2022 09:03 ET
|
NovaSignal Corporation
LOS ANGELES, April 28, 2022 (GLOBE NEWSWIRE) -- NovaSignal Corp., a medical technology and data company specializing in the assessment and management of brain health, today announced the launch of a...